ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 74 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $1,345,000 | -56.3% | 25,164 | -7.7% | 0.21% | -47.9% |
Q4 2015 | $3,079,000 | +212.0% | 27,253 | +59.7% | 0.40% | +253.5% |
Q1 2015 | $987,000 | +0.2% | 17,070 | -44.1% | 0.11% | -16.8% |
Q4 2014 | $985,000 | -19.3% | 30,558 | -38.7% | 0.14% | -44.8% |
Q3 2014 | $1,220,000 | +38.0% | 49,865 | 0.0% | 0.25% | +47.6% |
Q2 2014 | $884,000 | -70.0% | 49,865 | -66.2% | 0.17% | -68.4% |
Q1 2014 | $2,950,000 | -4.6% | 147,445 | -20.0% | 0.53% | -4.0% |
Q4 2013 | $3,093,000 | +40.7% | 184,321 | -10.9% | 0.55% | +26.5% |
Q3 2013 | $2,198,000 | – | 206,933 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |